About James Bauler
Form D filings for Fuse Oncology from 2022 to 2023 list James Bauler as chief executive officer and director.
James Bauler first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name James Bauler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Bauler works with at each company, as listed on that company's latest Form D.
Fuse Oncology, Inc. · Form D, Apr 21, 2023
JM
John Miller
Director
JB
Jay Brennan
Director
BS
Benjamin Sintay
Executive officer
JS
John Strider
Executive officer
DW
David Wiant
Executive officer